We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
201
Kraft Heinz
KHC
$30.7B
$240K ﹤0.01%
+7,457
New +$266K
BN icon
202
Brookfield
BN
$104B
$236K ﹤0.01%
8,505
-17,094
-67% -$476K
APVO icon
203
Aptevo Therapeutics
APVO
$5.12M
$229K ﹤0.01%
+56
New +$836K
MTB icon
204
M&T Bank
MTB
$35.7B
$229K ﹤0.01%
1,512
-34,408
-96% -$5.03M
DTE icon
205
DTE Energy
DTE
$29.5B
$223K ﹤0.01%
+2,009
New +$225K
BGMS
206
Bio Green Med Solution Inc
BGMS
$4.91M
$217K ﹤0.01%
+558
New +$268K
ANF icon
207
Abercrombie & Fitch
ANF
$4.42B
$216K ﹤0.01%
1,213
-3,309
-73% -$480K
DBGI
208
Digital Brands Group
DBGI
$8.88M
$215K ﹤0.01%
+74
New +$376K
ELAN icon
209
Elanco Animal Health
ELAN
$13.2B
$214K ﹤0.01%
14,811
-11,714
-44% -$187K
GENE
210
DELISTED
Genetic Technologies Ltd.
GENE
$210K ﹤0.01%
+140,000
New +$315K
SNGX icon
211
Soligenix
SNGX
$5.54M
$206K ﹤0.01%
+80,000
New +$461K
BPTH
212
DELISTED
Bio-Path Holdings Inc
BPTH
$194K ﹤0.01%
+97,000
New +$266K
RKTO
213
Rocket One Inc
RKTO
$17.9M
$194K ﹤0.01%
213,000
-197,000
-48% -$227K
FGIWW
214
FGI Industries Warrant
FGIWW
$189K
$176K ﹤0.01%
933,333
– –
CING icon
215
Cingulate
CING
$64.5M
$157K ﹤0.01%
+40,833
New +$397K
GRDX
216
GridAI Technologies Corp
GRDX
$20.4M
$155K ﹤0.01%
42,000
+33,000
+367% +$272K
PRFX icon
217
PRF Technologies Ltd
PRFX
$3.04M
$132K ﹤0.01%
2,300
+1,000
+77% +$104K
HSDT icon
218
Solana Company
HSDT
$96.3M
$127K ﹤0.01%
+173
New +$367K
PALI icon
219
Palisade Bio
PALI
$330M
$125K ﹤0.01%
27,858
-20,142
-42% -$110K
GT icon
220
Goodyear
GT
$2B
$114K ﹤0.01%
10,049
-21,871
-69% -$268K
NXLIW
221
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$111K ﹤0.01%
325,000
– –
BCTXW
222
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$101K ﹤0.01%
375,000
– –
ONFOW icon
223
Onfolio Holdings Warrant
ONFOW
$99.5K ﹤0.01%
400,000
– –
STKH
224
Steakholder Foods
STKH
$1.42M
$98.8K ﹤0.01%
224
-5,938
-96% -$3.03M
HBM icon
225
Hudbay
HBM
$10.1B
$97.5K ﹤0.01%
+10,770
New +$93.5K
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.